- Home
- Publications
- Publication Search
- Publication Details
Title
Liver Transplantation for Hilar Cholangiocarcinoma
Authors
Keywords
-
Journal
SURGICAL CLINICS OF NORTH AMERICA
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-20
DOI
10.1016/j.suc.2023.09.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant
- (2023) Samuel J. Keltner et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Liver Transplantation as a New Standard of Care in Patients with Perihilar Cholangiocarcinoma? Results from an International Benchmark Study
- (2022) Eva Breuer et al. ANNALS OF SURGERY
- AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
- (2022) Christopher L. Bowlus et al. HEPATOLOGY
- Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma
- (2022) Casey M. Silver et al. JOURNAL OF SURGICAL ONCOLOGY
- Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)
- (2022) Moritz Schmelzle et al. Frontiers in Oncology
- Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age
- (2020) Palak J. Trivedi et al. GASTROENTEROLOGY
- Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
- (2020) Jaynee J. A. Vugts et al. ANNALS OF SURGICAL ONCOLOGY
- Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization
- (2017) Pim B. Olthof et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Epidemiology and risk factors: intrahepatic cholangiocarcinoma
- (2017) Amar Gupta et al. HEPATOBILIARY SURGERY AND NUTRITION
- Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
- (2016) Supriya K. Saha et al. ONCOLOGIST
- Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo Hilar Cholangiocarcinoma?
- (2015) Kristopher P. Croome et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Hilar Cholangiocarcinoma: expert consensus statement
- (2015) John C. Mansour et al. HPB
- Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma
- (2013) Theodore H. Welling et al. LIVER TRANSPLANTATION
- Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review
- (2013) Jan Grendar et al. HPB
- Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
- (2012) Sarwa Darwish Murad et al. GASTROENTEROLOGY
- Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma
- (2012) Sarwa Darwish Murad et al. HEPATOLOGY
- The Blumgart Preoperative Staging System for Hilar Cholangiocarcinoma: Analysis of Resectability and Outcomes in 380 Patients
- (2012) Kenichi Matsuo et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination
- (2011) Julie K. Heimbach et al. HPB
- Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience
- (2009) Flavio G. Rocha et al. Journal of Hepato-Biliary-Pancreatic Sciences
- High lifetime risk of cancer in primary sclerosing cholangitis
- (2008) Marian M.H. Claessen et al. JOURNAL OF HEPATOLOGY
- Surgery for cholangiocarcinoma: the role of liver transplantation
- (2008) C.B. Rosen et al. HPB
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started